德克薩斯州休斯頓，2025年3月3日（全球新聞網絡）-- Nexalin科技公司（納斯達克：NXL；NXLIW）（"公司"或"Nexalin"）是大腦深層顱內頻率刺激（DIFS）領域的領導者，今天宣佈已收到美國專利商標局（USPTO）對其專利申請的允許通知，該申請標題爲"用於阿片類藥物使 …

Find the latest Nexalin Technology, Inc. (NXL) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get the latest Nexalin Technology Inc (NXL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions ...

查看即時Nexalin Technology, Inc.圖表以追踪其股票的價格行為。查找市場預測，NXL財務和市場新聞。

5 天之前 · Get a real-time Nexalin Technology, Inc. (NXL) stock price with an overview of financials, statistics, forecasts, charts and more.

Nexalin Technology, Inc.(NXL)，Yahoo奇摩股市提供您即時報價、個股走勢、成交資訊、當日籌碼，價量變化、個股相關新聞等即時資訊。

2022年9月16日 · 该公司开发了一种易于管理的医疗设备——被称为“Generation 1”或“Gen-1”——利用生物电子医疗技术治疗焦虑和失眠，无需药物或心理治疗。 该公司最初的Gen-1设备是颅电疗法刺激（CES）设备，在治疗期间以4毫安的速度发射波形，目前被美国食品药品监督管理局（“FDA”）归类为II类设备。 Nexalin Technology (NXL) 01-25 06:05. $Nexalin Technology (NXL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: …

5 天之前 · Get the latest Nexalin Technology, Inc NXL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

2025年3月15日 · Should You Buy or Sell Nexalin Technology Stock? Get The Latest NXL Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

Nexalin Technology, Inc. Announces UCSD IRB Approval for use of HALO? Clarity in Clinical Trials for mTBI and PTSD Treatment. Certain Warrant of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025. Certain Common Stock of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025.